The preferred drug for treating attention deficit hyperactivity disorder in a 6 year old boy, whose father has a history of substance abuse:-
**Question:** The preferred drug for treating attention deficit hyperactivity disorder in a 6 year old boy, whose father has a history of substance abuse:
A. Methylphenidate
B. Dextroamphetamine
C. Atomoxetine
D. Guanfacine
**Correct Answer:** C. Atomoxetine
**Core Concept:**
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. Children with ADHD often have comorbidities, such as substance abuse in the family history. In such cases, clinicians need to consider factors like potential medication side effects and drug interactions.
**Why the Correct Answer is Right:**
Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor (SNRi) commonly used in the treatment of ADHD. It is a first-line treatment option for children and adolescents, including those aged 6 years, as it is generally well-tolerated and has fewer side effects compared to stimulants like methylphenidate and dextroamphetamine.
**Why Each Wrong Option is Incorrect:**
A. Methylphenidate (Ritalin): Methylphenidate is a psychostimulant that enhances norepinephrine and dopamine neurotransmission. However, in a child with a substance abuse history in the family, clinicians should be cautious due to potential drug interactions and misuse concerns.
B. Dextroamphetamine (Dexedrine): Similar to methylphenidate, dextroamphetamine (a psychostimulant) may not be the best choice for a 6-year-old due to the risk of side effects and potential drug interactions in a child with a substance abuse history.
C. Atomoxetine (Strattera): As mentioned earlier, atomoxetine is an SNRI that selectively inhibits norepinephrine reuptake without significantly affecting dopamine reuptake. This makes atomoxetine a safer choice than psychostimulants, considering the child's age and family history of substance abuse.
D. Guanfacine (Intuniv): Guanfacine is an alpha-2 adrenergic receptor agonist commonly used for ADHD treatment. However, its mechanism of action differs from atomoxetine, and it is generally less effective for younger children.
**Clinical Pearl:** When treating a child with ADHD and a family history of substance abuse, clinicians should consider the potential for drug interactions and misuse in the context of the child's age and family history. Atomoxetine is a safer choice due to its selective norepinephrine reuptake inhibition without significant dopamine reuptake inhibition, which makes it safer than psychostimulants for a 6-year-old child with ADHD and a family history of substance abuse.